Ipca Labs drug gets WHO pre-qualification
WHO's pre-qualification product list is used by agencies of the United Nations and other organisations to guide them in their procurement decisions.
Indian drug maker Ipca Laboratories Ltd said on Wednesday its anti-malarial combination drug, artemether and lumefantrine, had been pre-qualified by the World Health Organization (WHO).
WHO's pre-qualification product list is used by agencies of the United Nations and other organisations to guide them in their procurement decisions.